Shailender Bhatia
University of Washington
H-index: 55
North America-United States
Top articles of Shailender Bhatia
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Cardiovascular Collapse Shortly After Beta Blockers in Atrial Fibrillation-complicated Thyroid Storm | S Bhatia A Jamil M Sharif S Skenderi | 2024/5 | |
Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma | Journal of the American Academy of Dermatology | Nora A Alexander Stephanie K Schaub Peter H Goff Daniel S Hippe Song Y Park | 2024/2/1 |
Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patients | Journal of the American Academy of Dermatology | Song Y Park Daniel S Hippe Lauren Zawacki Marika Bierma Shailender Bhatia | 2024/1/4 |
Adverse events of immune checkpoint therapy alone versus when combined with vascular endothelial growth factor inhibitors: a pooled meta-analysis of 1735 patients | Iuliia Kovalenko Wern Lynn Ng Yimin Geng Yinghong Wang Pavlos Msaouel | 2024/1/4 | |
Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec | JAAD Case Reports | Neha Singh Erin McClure Coley Doolittle-Amieva Upendra Parvathaneni Shailender Bhatia | 2023/6/1 |
610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal … | Peter H Goff Kelsey K Baker Sylvia M Lee Scott S Tykodi Shailender Bhatia | 2023/11/1 | |
LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L) 1 immunotherapy | Journal of Investigative Dermatology | L Tachiki Y Moshiri Yi DS Hippe L Zawacki E Gong | 2023/9/1 |
ANAYLSIS AND IMPLEMENTATION OF APP TRIAGE PILOT | Oncology Nursing Forum | Trisha Marsolini Kari Thomas Andrea Perdue Shailender Bhatia | 2023/3/1 |
819 Concurrent treatment with GM-CSF immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic … | Natalie J Miller Jacob Leary William McCamy Joshua Veatch Evan Hall | 2023/11/1 | |
Understanding the late immune checkpoint inhibitor (ICI) symptom experience using an electronic patient reported outcomes (ePRO) app-based platform: The immunowave study. | Anissa Chan Salene MW Jones Emily Enright Aleksandra Raczka Vivian Nguyen | 2023/6/1 | |
Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvec | JAAD Case Reports | Erin M McClure Neha Singh Kim G Abson Shailender Bhatia Heidi J Gray | 2023/2/1 |
1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial | Sapna P Patel Richard Carvajal Kamaneh Montazeri Sunil Reddy Jose Lutzky | 2023/11/1 | |
Non-comparative, open-label, international, multicenter phase I/II study of nivolumab (NIVO)±ipilimumab (IPI) in patients (pts) with recurrent/metastatic merkel cell carcinoma … | Shailender Bhatia Suzanne Louise Topalian William Howard Sharfman Tim Meyer Christopher D Lao | 2023/6/1 | |
Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study | Clinical Cancer Research | Funda Meric-Bernstam Randy F Sweis Stefan Kasper Omid Hamid Shailender Bhatia | 2023/1/4 |
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma | Cancer Immunology, Immunotherapy | Lisa May Ling Tachiki Daniel S Hippe Karly Williams Silva Evan Thomas Hall William McCamy | 2023/11 |
Association between symptoms and health-related quality of life in patients with cancer with prior or ongoing immune checkpoint inhibitor therapy exposure. | Salene MW Jones Anissa Chan Emily Enright Aleksandra Raczka Vivian Nguyen | 2023/6/1 | |
1146P Updated results from POD1UM-201: A phase II study of retifanlimab in patients with advanced or metastatic Merkel cell carcinoma (MCC) | Annals of Oncology | G Grignani P Rutkowski C Lebbe M Guida C Gaudy Marqueste | 2023/10/1 |
A phase 1 study of AGEN2373, a novel CD137 agonist antibody designed to avoid hepatoxicity, in patients with advanced solid tumors. | Minal A Barve Anthony W Tolcher Richard D Carvajal Benjamin Izar Anthony B El-Khoueiry | 2023/6/1 | |
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma | Journal for immunotherapy of cancer | Gino Kim In Aparna Nallagangula Jacob Seung Choi Lisa Tachiki Matthew J Blackburn | 2022 |
Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function | Cancer Cell | Joshua R Veatch Sylvia M Lee Carolyn Shasha Naina Singhi Julia L Szeto | 2022/4/11 |
Co-Authors
